IL198678A0 - Liquid pharmaceutical compositions comprising a bisphosphonate compound - Google Patents

Liquid pharmaceutical compositions comprising a bisphosphonate compound

Info

Publication number
IL198678A0
IL198678A0 IL198678A IL19867809A IL198678A0 IL 198678 A0 IL198678 A0 IL 198678A0 IL 198678 A IL198678 A IL 198678A IL 19867809 A IL19867809 A IL 19867809A IL 198678 A0 IL198678 A0 IL 198678A0
Authority
IL
Israel
Prior art keywords
pharmaceutical compositions
liquid pharmaceutical
bisphosphonate compound
bisphosphonate
compound
Prior art date
Application number
IL198678A
Other languages
English (en)
Original Assignee
Besins Healthcare
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP06291785A external-priority patent/EP1923049A1/en
Priority claimed from EP06291786A external-priority patent/EP1923050A1/en
Application filed by Besins Healthcare filed Critical Besins Healthcare
Publication of IL198678A0 publication Critical patent/IL198678A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
IL198678A 2006-11-17 2009-05-11 Liquid pharmaceutical compositions comprising a bisphosphonate compound IL198678A0 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US86630606P 2006-11-17 2006-11-17
US86629406P 2006-11-17 2006-11-17
EP06291785A EP1923049A1 (en) 2006-11-17 2006-11-17 Pharmaceutical compositions comprising a bisphosphonate compound
EP06291786A EP1923050A1 (en) 2006-11-17 2006-11-17 Liquid pharmaceutical compositions comprising a bisphosphonate compound
PCT/EP2007/062473 WO2008059060A1 (en) 2006-11-17 2007-11-16 Liquid pharmaceutical compositions comprising a bisphosphonate compound

Publications (1)

Publication Number Publication Date
IL198678A0 true IL198678A0 (en) 2010-02-17

Family

ID=38895592

Family Applications (2)

Application Number Title Priority Date Filing Date
IL198678A IL198678A0 (en) 2006-11-17 2009-05-11 Liquid pharmaceutical compositions comprising a bisphosphonate compound
IL198698A IL198698A0 (en) 2006-11-17 2009-05-12 Pharmaceutical compositions comprising a bisphosphonate compound

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL198698A IL198698A0 (en) 2006-11-17 2009-05-12 Pharmaceutical compositions comprising a bisphosphonate compound

Country Status (9)

Country Link
US (2) US20080182822A1 (cg-RX-API-DMAC7.html)
EP (2) EP2088996A1 (cg-RX-API-DMAC7.html)
JP (2) JP2010510194A (cg-RX-API-DMAC7.html)
AR (2) AR064262A1 (cg-RX-API-DMAC7.html)
AU (2) AU2007321108A1 (cg-RX-API-DMAC7.html)
CA (2) CA2669488A1 (cg-RX-API-DMAC7.html)
IL (2) IL198678A0 (cg-RX-API-DMAC7.html)
TW (2) TW200829282A (cg-RX-API-DMAC7.html)
WO (2) WO2008059060A1 (cg-RX-API-DMAC7.html)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2088996A1 (en) * 2006-11-17 2009-08-19 Besins Healthcare Liquid pharmaceutical compositions comprising a bisphosphonate compound
EP2147674A1 (en) * 2008-07-24 2010-01-27 Besins Healthcare Transdermal pharmaceutical compositions comprising danazol
US9169279B2 (en) 2009-07-31 2015-10-27 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
US20160016982A1 (en) 2009-07-31 2016-01-21 Thar Pharmaceuticals, Inc. Crystallization method and bioavailability
SI2459176T1 (en) * 2009-07-31 2018-01-31 Gruenenthal Gmbh Crystallization process and bioavailability
US9340565B2 (en) 2010-11-24 2016-05-17 Thar Pharmaceuticals, Inc. Crystalline forms
US10195218B2 (en) 2016-05-31 2019-02-05 Grunenthal Gmbh Crystallization method and bioavailability
WO2019232114A1 (en) * 2018-06-01 2019-12-05 The University Of North Carolina At Chapel Hill Injectable thermoresponsive hydrogels as a combinatory modality for controlled drug delivery, biomaterial implant and 3d printing bioink

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX21453A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
MX21452A (es) * 1989-07-07 1994-01-31 Ciba Geigy Ag Preparaciones farmaceuticas que se administran en forma topica.
GB9408775D0 (en) * 1994-05-04 1994-06-22 Ciba Geigy Ag Use of certain methanebisphosphonic acid derivatives to prevent prothesis loosening and prothesis migration
JP3411690B2 (ja) * 1994-09-21 2003-06-03 帝人株式会社 局所投与用アレンドロン酸ナトリウム製剤
US6905701B2 (en) * 1997-06-11 2005-06-14 Umd, Inc. Formulations for transmucosal vaginal delivery of bisphosphonates
WO2000028982A2 (en) * 1998-11-19 2000-05-25 The Board Of Trustees For The University Of Arkansas Increasing bone strength with selected bisphosphonates
US20050074487A1 (en) * 1999-12-16 2005-04-07 Tsung-Min Hsu Transdermal and topical administration of drugs using basic permeation enhancers
JP2001253827A (ja) * 2000-02-15 2001-09-18 Pfizer Prod Inc 骨粗鬆症を治療するための組成物および方法
KR100492110B1 (ko) * 2000-05-05 2005-06-02 에프. 호프만-라 로슈 아게 비스포스폰산 또는 그의 염을 포함하는 피하 투여용겔-유사 약학 조성물
JP4394888B2 (ja) * 2002-02-14 2010-01-06 救急薬品工業株式会社 経皮投与製剤
KR100998856B1 (ko) 2002-02-14 2010-12-08 규큐 야쿠힝 고교 가부시키가이샤 경피투여제제
WO2005007100A2 (en) * 2003-07-11 2005-01-27 Macrochem Corporation Pharmaceutical compositions for topical application
MY141763A (en) * 2003-09-18 2010-06-30 Novartis Ag Pharmaceutical products comprising bisphosphonates
US20050119230A1 (en) * 2003-09-18 2005-06-02 Alexandra Glausch Pharmaceutical products comprising bisphosphonated
EP1682060A1 (en) * 2003-10-14 2006-07-26 Dermatrends, Inc. Enhancing transdermal administration of hydrophilic drugs
EP2088996A1 (en) * 2006-11-17 2009-08-19 Besins Healthcare Liquid pharmaceutical compositions comprising a bisphosphonate compound

Also Published As

Publication number Publication date
EP2114368A1 (en) 2009-11-11
TW200829282A (en) 2008-07-16
AR064263A1 (es) 2009-03-25
IL198698A0 (en) 2010-02-17
CA2669489A1 (en) 2008-05-22
WO2008059059A1 (en) 2008-05-22
US20080182822A1 (en) 2008-07-31
US20080167271A1 (en) 2008-07-10
JP2010510195A (ja) 2010-04-02
AU2007321109A2 (en) 2009-06-11
AR064262A1 (es) 2009-03-25
TW200831130A (en) 2008-08-01
AU2007321108A1 (en) 2008-05-22
WO2008059060A1 (en) 2008-05-22
AU2007321109A1 (en) 2008-05-22
EP2088996A1 (en) 2009-08-19
JP2010510194A (ja) 2010-04-02
CA2669488A1 (en) 2008-05-22

Similar Documents

Publication Publication Date Title
IL193243A0 (en) Pharmaceutical compositions containing a thiazolidinedione derivative
IL194762A0 (en) Pharmaceutical compounds
EP2001498A4 (en) PHARMACEUTICAL COMPOSITIONS
IL194176A0 (en) Pharmaceutical compositions
GB0713625D0 (en) Pharmaceutical compositions
ZA200809479B (en) New pharmaceutical compounds
LT3103448T (lt) Farmacinės kompozicijos, apimančios s1p moduliatorių
PL2124556T3 (pl) Kompozycje farmaceutyczne
GB0608820D0 (en) Pharmaceutical compounds
IL248492A0 (en) Pharmaceutical preparations for administration into the ventricles of the brain
IL198678A0 (en) Liquid pharmaceutical compositions comprising a bisphosphonate compound
GB0608176D0 (en) Pharmaceutical Compounds
GB0608184D0 (en) Pharmaceutical compounds
GB0608175D0 (en) Pharmaceutical Compounds
GB0608264D0 (en) Pharmaceutical compounds
GB0625682D0 (en) Pharmaceutical compounds
GB0622892D0 (en) Pharmaceutical compounds
GB0610311D0 (en) Bisphosphonate formulation
GB0613520D0 (en) Pharmaceutical compounds
GB0608185D0 (en) Pharmaceutical Compounds
GB0614456D0 (en) Pharmaceutical compounds
GB0604111D0 (en) Pharmaceutical compounds
GB0611565D0 (en) Pharmaceutical compounds
GB0608179D0 (en) Pharmaceutical compounds
GB0615299D0 (en) Pharmaceutical compounds